| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.075 | 0.009 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |